Document is current
Any future updates will be listed below
-
Authors
von Oldenburg, Natalie
Pick, Noelle
Semin, Jessica N.
Free, Marcia
Ernst, Weston
Hill-Polerecky, Diane M.
Miller, Kimberly A.
Bhatt, Vijaya R.
Wildes, Tanya M.
Estabrooks, Paul A.
Fisher, Alfred L.
Jones, Katherine J.
Koll, Thuy T.
-
Funding
Funding for this research was provided by:
Fred and Pamela Buffett Cancer Center Support Grant from the National Cancer Institute (P30 CA036727, P30 CA036727)
National Cancer Institute of the National Institutes of Health (R37 CA276928)
National Institute on Aging (K23AG070311)
- License Information
-
More Information
Article History
Received: 30 July 2024
Accepted: 23 March 2025
First Online: 17 April 2025
Declarations
:
: VRB reports participating in the Safety Monitoring Committee for Protagonist, serving as an Associate Editor for the journal, Current Problems in Cancer, and as a contributor for BMJ Best Practice, and receiving consulting fees from Imugene, Sanofi, Taiho, research funding (institutional) from MEI Pharma, Actinium Pharmaceutical, Sanofi US Services, Abbvie, Pfizer, Incyte, Jazz, and National Marrow Donor Program, and drug support (institutional) from Chimerix for a trial. All other authors have no conflicts of interest to report.The authors declare no competing interests.
